Progress in current non-viral carriers for gene delivery

Yoko Shoji-Moskowitz, Daisuke Asai, Kota Kodama, Yoshiki Katayama, Hideki Nakashima

Research output: Contribution to journalArticle

6 Citations (Scopus)


Since the viral vector for gene therapy has serious problems, including oncogenesity and other adverse effects, non-viral carriers have attracted a great deal of attention. However, the most critical issue of gene delivery by non-viral carriers is the low-expression efficiencies of the desired gene. In order to apply non-viral carriers for gene therapy in practical clinical usage, the improvement of transfection efficiency is a prerequisite. We will summarize the current progress of non-viral delivery systems for gene therapy. Especially, we will address the applications of cationic lipids (lipoplex) and cationic polymers (polyplex) in vivo. Furthermore, there have been reported a disease-site-specific delivery system which responds to highly activated cellular signals, which is called a drug delivery system based on responses cellular signal (D-RECS). We will also introduce the current progress of D-RECS gene delivery which is activated by HIV protease in only HIV-infected cells.

Original languageEnglish
Pages (from-to)81-97
Number of pages17
JournalFrontiers in Medicinal Chemistry
Issue number1
Publication statusPublished - Jan 1 2010


All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Drug Discovery
  • Organic Chemistry

Cite this

Shoji-Moskowitz, Y., Asai, D., Kodama, K., Katayama, Y., & Nakashima, H. (2010). Progress in current non-viral carriers for gene delivery. Frontiers in Medicinal Chemistry, 5(1), 81-97.